133 related articles for article (PubMed ID: 37992927)
1. Recombinant human HspB5-ACD structural domain inhibits neurotoxicity by regulating pathological α-Syn aggregation.
Liu C; Ding X; Guo X; Zhao M; Zhang X; Li Z; Zhao R; Cao Y; Xing J
Int J Biol Macromol; 2024 Jan; 255():128311. PubMed ID: 37992927
[TBL] [Abstract][Full Text] [Related]
2. Biological effects and mechanism of β-amyloid aggregation inhibition by penetrable recombinant human HspB5-ACD structural domain protein.
Liu C; Ding X; Zhao M; Chen C; Zhang X; Zhao R; Chen Y; Xie Y
Biomed Pharmacother; 2024 Jun; 175():116661. PubMed ID: 38678965
[TBL] [Abstract][Full Text] [Related]
3. Monoamine Oxidase-B Inhibition Facilitates α-Synuclein Secretion
Nakamura Y; Arawaka S; Sato H; Sasaki A; Shigekiyo T; Takahata K; Tsunekawa H; Kato T
J Neurosci; 2021 Sep; 41(35):7479-7491. PubMed ID: 34290084
[TBL] [Abstract][Full Text] [Related]
4. Interaction between Neuromelanin and Alpha-Synuclein in Parkinson's Disease.
Xu S; Chan P
Biomolecules; 2015 Jun; 5(2):1122-42. PubMed ID: 26057626
[TBL] [Abstract][Full Text] [Related]
5. Binding of Noradrenaline to Native and Intermediate States during the Fibrillation of α-Synuclein Leads to the Formation of Stable and Structured Cytotoxic Species.
Singh P; Bhat R
ACS Chem Neurosci; 2019 Jun; 10(6):2741-2755. PubMed ID: 30917654
[TBL] [Abstract][Full Text] [Related]
6. Biasing the native α-synuclein conformational ensemble towards compact states abolishes aggregation and neurotoxicity.
Carija A; Pinheiro F; Pujols J; Brás IC; Lázaro DF; Santambrogio C; Grandori R; Outeiro TF; Navarro S; Ventura S
Redox Biol; 2019 Apr; 22():101135. PubMed ID: 30769283
[TBL] [Abstract][Full Text] [Related]
7. Synthetic alpha-synuclein fibrils cause mitochondrial impairment and selective dopamine neurodegeneration in part via iNOS-mediated nitric oxide production.
Tapias V; Hu X; Luk KC; Sanders LH; Lee VM; Greenamyre JT
Cell Mol Life Sci; 2017 Aug; 74(15):2851-2874. PubMed ID: 28534083
[TBL] [Abstract][Full Text] [Related]
8. α-Synuclein protects against manganese neurotoxic insult during the early stages of exposure in a dopaminergic cell model of Parkinson's disease.
Harischandra DS; Jin H; Anantharam V; Kanthasamy A; Kanthasamy AG
Toxicol Sci; 2015 Feb; 143(2):454-68. PubMed ID: 25416158
[TBL] [Abstract][Full Text] [Related]
9. Alteration of Structure and Aggregation of α-Synuclein by Familial Parkinson's Disease Associated Mutations.
Sahay S; Ghosh D; Singh PK; Maji SK
Curr Protein Pept Sci; 2017; 18(7):656-676. PubMed ID: 26972727
[TBL] [Abstract][Full Text] [Related]
10. α-Synuclein aggregation and transmission in Parkinson's disease: a link to mitochondria and lysosome.
Wang R; Sun H; Ren H; Wang G
Sci China Life Sci; 2020 Dec; 63(12):1850-1859. PubMed ID: 32681494
[TBL] [Abstract][Full Text] [Related]
11. The disordered protein SERF promotes α-Synuclein aggregation through liquid-liquid phase separation.
Liu HN; Wang T; Hu JJ; Chen L; Shi X; Li YM; Luo SZ
J Biol Chem; 2024 Mar; 300(3):105667. PubMed ID: 38272228
[TBL] [Abstract][Full Text] [Related]
12. A simple, versatile and robust centrifugation-based filtration protocol for the isolation and quantification of α-synuclein monomers, oligomers and fibrils: Towards improving experimental reproducibility in α-synuclein research.
Kumar ST; Donzelli S; Chiki A; Syed MMK; Lashuel HA
J Neurochem; 2020 Apr; 153(1):103-119. PubMed ID: 31925956
[TBL] [Abstract][Full Text] [Related]
13. C-terminal truncation exacerbates the aggregation and cytotoxicity of α-Synuclein: A vicious cycle in Parkinson's disease.
Ma L; Yang C; Zhang X; Li Y; Wang S; Zheng L; Huang K
Biochim Biophys Acta Mol Basis Dis; 2018 Dec; 1864(12):3714-3725. PubMed ID: 30290273
[TBL] [Abstract][Full Text] [Related]
14. Nortriptyline inhibits aggregation and neurotoxicity of alpha-synuclein by enhancing reconfiguration of the monomeric form.
Collier TJ; Srivastava KR; Justman C; Grammatopoulous T; Hutter-Paier B; Prokesch M; Havas D; Rochet JC; Liu F; Jock K; de Oliveira P; Stirtz GL; Dettmer U; Sortwell CE; Feany MB; Lansbury P; Lapidus L; Paumier KL
Neurobiol Dis; 2017 Oct; 106():191-204. PubMed ID: 28711409
[TBL] [Abstract][Full Text] [Related]
15. Small molecule-based fluorescent probes for the detection of α-Synuclein aggregation states.
Haque R; Maity D
Bioorg Med Chem Lett; 2023 Apr; 86():129257. PubMed ID: 36966976
[TBL] [Abstract][Full Text] [Related]
16. Dl-3-n-Butylphthalide Rescues Dopaminergic Neurons in Parkinson's Disease Models by Inhibiting the NLRP3 Inflammasome and Ameliorating Mitochondrial Impairment.
Que R; Zheng J; Chang Z; Zhang W; Li H; Xie Z; Huang Z; Wang HT; Xu J; Jin D; Yang W; Tan EK; Wang Q
Front Immunol; 2021; 12():794770. PubMed ID: 34925379
[TBL] [Abstract][Full Text] [Related]
17. The deglycase activity of DJ-1 mitigates α-synuclein glycation and aggregation in dopaminergic cells: Role of oxidative stress mediated downregulation of DJ-1 in Parkinson's disease.
Sharma N; Rao SP; Kalivendi SV
Free Radic Biol Med; 2019 May; 135():28-37. PubMed ID: 30796974
[TBL] [Abstract][Full Text] [Related]
18. Ellagic Acid Prevents α-Synuclein Aggregation and Protects SH-SY5Y Cells from Aggregated α-Synuclein-Induced Toxicity via Suppression of Apoptosis and Activation of Autophagy.
Ardah MT; Eid N; Kitada T; Haque ME
Int J Mol Sci; 2021 Dec; 22(24):. PubMed ID: 34948195
[TBL] [Abstract][Full Text] [Related]
19. Targeting α-synuclein aggregation and its role in mitochondrial dysfunction in Parkinson's disease.
Haque ME; Akther M; Azam S; Kim IS; Lin Y; Lee YH; Choi DK
Br J Pharmacol; 2022 Jan; 179(1):23-45. PubMed ID: 34528272
[TBL] [Abstract][Full Text] [Related]
20. Sequestration of synaptic proteins by alpha-synuclein aggregates leading to neurotoxicity is inhibited by small peptide.
Choi MG; Kim MJ; Kim DG; Yu R; Jang YN; Oh WJ
PLoS One; 2018; 13(4):e0195339. PubMed ID: 29608598
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
